DOI: 10.36347/sjams.2015.v03i04.029

Pages: 1748-1751

Iron deficiency anaemia (IDA) is the most common nutritional deficiency anaemia in pregnant women. About half of the global maternal deaths due to anaemia occur in South Asian countries; India contributing to about 80% of this mortality ratio. Intravenous iron-sucrose appears to be a treatment of choice. To evaluate the effect of intravenous Iron-Sucrose complex in terms of improvement in haemoglobin status over 3 weeks following infusion in pregnant women diagnosed with IDA.2) To know any immediate side effects of the therapy on maternal condition and on foetal condition. A cross sectional study was conducted, where all the pregnant women within the inclusion criteria, attending the OPD of the Department of OBG, Cheluvamba Hospital, Mysore, were recruited. Study period was 1-06-2014 to 31-07-2014. The Hb status of pregnant women who were clinically diagnosed with anaemia was estimated by Sahli’s acid- haematin method then Iron-Sucrose was given. Initially the mean Hb status of the subjects was 6.159±0.7510 gm%. In the first week following iron sucrose transfusion, there was a rise in the mean Hb status to 7.015±0.7576 gm% . The second week showed a further increase in the levels to 7.85±0.695 gm%. In the third week the mean Hb status was found to be 8.625±0.6606 gm%. The overall increase in haemoglobin level was found to be significant. Intravenous iron sucrose transfusion is an effective treatment strategy for pregnant patients with severe anaemia during late pregnancy and in patient’s non compliant to oral therapy.